Robert A. Nelimark

905 total citations
11 papers, 676 citations indexed

About

Robert A. Nelimark is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Robert A. Nelimark has authored 11 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Reproductive Medicine. Recurrent topics in Robert A. Nelimark's work include Lung Cancer Research Studies (3 papers), Estrogen and related hormone effects (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Robert A. Nelimark is often cited by papers focused on Lung Cancer Research Studies (3 papers), Estrogen and related hormone effects (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Robert A. Nelimark collaborates with scholars based in United States and Canada. Robert A. Nelimark's co-authors include Charles L. Loprinzi, Judith R. OʼFallon, Ann Marie Dose, John C. Michalak, Tammy Fischer, Susan K. Quella, Joseph E. Oesterling, Raylene M. Rospond, Alan K. Hatfield and John W. Kugler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Robert A. Nelimark

11 papers receiving 637 citations

Peers

Robert A. Nelimark
K. Gary Barnette United States
K.-D. Schulz Germany
P Stattin Sweden
Bo Lin China
G. Bartsch Austria
Charles Carmeci United States
D.S. Allen United Kingdom
Philip A. DeSimone United States
K. Gary Barnette United States
Robert A. Nelimark
Citations per year, relative to Robert A. Nelimark Robert A. Nelimark (= 1×) peers K. Gary Barnette

Countries citing papers authored by Robert A. Nelimark

Since Specialization
Citations

This map shows the geographic impact of Robert A. Nelimark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Nelimark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Nelimark more than expected).

Fields of papers citing papers by Robert A. Nelimark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Nelimark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Nelimark. The network helps show where Robert A. Nelimark may publish in the future.

Co-authorship network of co-authors of Robert A. Nelimark

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Nelimark. A scholar is included among the top collaborators of Robert A. Nelimark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Nelimark. Robert A. Nelimark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Loprinzi, Charles L., John W. Kugler, Debra L. Barton, et al.. (2006). Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5. Journal of Clinical Oncology. 25(3). 308–312. 69 indexed citations
4.
Elliott, Thomas E., Robert P. Dinapoli, Judith R. OʼFallon, et al.. (1997). Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. Journal of Neuro-Oncology. 33(3). 239–250. 22 indexed citations
5.
Loprinzi, Charles L., John C. Michalak, Susan K. Quella, et al.. (1995). Megestrol Acetate for the Prevention of Hot Flashes. Obstetrical & Gynecological Survey. 50(2). 135–137. 6 indexed citations
6.
Loprinzi, Charles L., John C. Michalak, Susan K. Quella, et al.. (1994). Megestrol Acetate for the Prevention of Hot Flashes. New England Journal of Medicine. 331(6). 347–352. 371 indexed citations
7.
Ingle, James N., Steven A. Kuross, James A. Mailliard, et al.. (1994). Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy. Cancer. 74(6). 1733–1738. 16 indexed citations
8.
Long, Harry J., Robert A. Nelimark, John Q. Su, et al.. (1994). Phase II Evaluation of 5-Fluorouracil and Low-Dose Leucovorin in Cisplatin-Refractory Advanced Ovarian Carcinoma. Gynecologic Oncology. 54(2). 180–183. 8 indexed citations
9.
Morton, Roscoe F., James R. Jett, William L. McGinnis, et al.. (1991). Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung Cancer. Annals of Internal Medicine. 115(9). 681–686. 140 indexed citations
10.
Krook, James E., Charles L. Loprinzi, Daniel J. Schaid, et al.. (1990). Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer a collaborative north central cancer treatment group/mayo clinic phase ii study. Cancer. 65(3). 418–421. 20 indexed citations
11.
Nelimark, Robert A., et al.. (1983). Vindesine for metastatic malignant melanoma. American Journal of Clinical Oncology. 6(5). 561–564. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026